| P2093 | author name string | Romney M Humphries | |
| | Janet A Hindler | |
| | April M Bobenchik | |
| | Carmen L Giltner | |
| | Sandra Saeki | |
| P2860 | cites work | Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro | Q44616846 |
| | Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. | Q46370151 |
| | Detection and prevalence of inducible clindamycin resistance in staphylococci | Q79808124 |
| | Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolide-lincosamide-streptogramin B resistance among clinical isolates of Staphylococcus | Q83416718 |
| | Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems | Q34041896 |
| | Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates | Q34719746 |
| | Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: report of a clinical failure and results of a questionnaire study | Q35139881 |
| | Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing | Q37421099 |
| | Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp. | Q39899618 |
| | VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus | Q40327375 |
| | Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital | Q40938285 |
| | Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium | Q41570641 |
| | BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin | Q41881612 |
| | Susceptibility of enterococci to daptomycin is dependent upon testing methodology | Q42261143 |
| | Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test | Q42280654 |
| | Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci | Q42637617 |
| | Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus | Q43097113 |
| | Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates. | Q43149111 |
| | Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance | Q43693151 |
| | Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children | Q44104837 |
| | Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes? | Q44345968 |
| | Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians | Q44579110 |
| | Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome. | Q44602409 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 392-397 | |
| P577 | publication date | 2013-11-13 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. | |
| P478 | volume | 52 | |